Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study.
Kelly G Gwathmey, Panru Jing, Scott Laorr et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the usability and acceptance of a prefilled syringe with needle safety device (PFS-SD) and an autoinjector (AI) among patients with generalized myasthenia gravis (gMG). The study found that 94% of participants using the PFS-SD and 96% using the AI successfully completed simulated use scenarios, indicating both devices are safe and effective for administration.
Key findings
- 94% of participants using the PFS-SD completed the simulated use scenario successfully.
- 96% of participants using the AI completed the simulated use scenario successfully.
- 90% of PFS-SD users and 87% of AI users successfully administered their assigned dose.
- Device acceptability was reported by 93% of PFS-SD users and 100% of AI users.
Why it matters
Understanding the usability and acceptance of injection devices is crucial for ensuring patient safety and adherence to treatment in chronic conditions like generalized myasthenia gravis. Effective device design can minimize administration errors and enhance patient confidence.